Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Walmart
WMT
|
$1.12B |
| 2 |
Microsoft
MSFT
|
$700M |
| 3 |
Walt Disney
DIS
|
$589M |
| 4 |
Linde
LIN
|
$549M |
| 5 |
Apple
AAPL
|
$486M |
Top Sells
| 1 |
Yum China
YUMC
|
$518M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$480M |
| 3 |
Synopsys
SNPS
|
$424M |
| 4 |
Workday
WDAY
|
$406M |
| 5 |
Meta Platforms (Facebook)
META
|
$364M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 12.22% |
| 3 | Industrials | 11.88% |
| 4 | Healthcare | 11.02% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
PDS Biotechnology
PDSB
$57.8M
| $73.4K | ﹤0.01% |
18,529
+280
| +2% | +$1.11K |
|
|
AUTL
3652
Autolus Therapeutics
AUTL
$399M
| $70.6K | ﹤0.01% |
11,071
+993
| +10% | +$6.34K |
|
3653
Empire Petroleum
EP
$171M
| $70.5K | ﹤0.01% |
+13,794
| New | +$70.5K |
|
3654
BioAtla
BCAB
$26.7M
| $70.1K | ﹤0.01% |
20,376
-763
| -4% | -$2.63K |
|
3655
ClearPoint Neuro
CLPT
$298M
| $69.2K | ﹤0.01% |
10,179
-20
| -0.2% | -$136 |
|
3656
Amylyx Pharmaceuticals
AMLX
$836M
| $69.2K | ﹤0.01% |
24,349
+454
| +2% | +$1.29K |
|
|
PPTA
3657
Perpetua Resources
PPTA
$2.03B
| $69.1K | ﹤0.01% |
16,607
-162
| -1% | -$674 |
|
3658
Trevi Therapeutics
TRVI
$883M
| $68.6K | ﹤0.01% |
19,888
| – | – |
|
3659
Humacyte
HUMA
$245M
| $68.3K | ﹤0.01% |
21,949
+856
| +4% | +$2.66K |
|
3660
Nautilus Biotechnolgy
NAUT
$85.9M
| $67.8K | ﹤0.01% |
23,062
+350
| +2% | +$1.03K |
|
3661
Envela
ELA
$194M
| $67.4K | ﹤0.01% |
+14,579
| New | +$67.4K |
|
3662
Precigen
PGEN
$1.34B
| $64.7K | ﹤0.01% |
44,612
+129
| +0.3% | +$187 |
|
3663
scPharmaceuticals
SCPH
$295M
| $63.8K | ﹤0.01% |
12,703
-72
| -0.6% | -$361 |
|
3664
ThredUp
TDUP
$1.33B
| $63.1K | ﹤0.01% |
31,546
-1,051
| -3% | -$2.1K |
|
3665
Standard BioTools
LAB
$481M
| $63K | ﹤0.01% |
23,264
+11,279
| +94% | +$30.6K |
|
3666
Generation Bio
GBIO
$40.4M
| $62.8K | ﹤0.01% |
15,427
-62,718
| -80% | -$255K |
|
3667
Tenaya Therapeutics
TNYA
$184M
| $62.4K | ﹤0.01% |
11,926
-793
| -6% | -$4.15K |
|
3668
NuScale Power
SMR
$4.64B
| $61.8K | ﹤0.01% |
11,642
-265
| -2% | -$1.41K |
|
3669
GrowGeneration
GRWG
$102M
| $60.8K | ﹤0.01% |
21,265
-100,784
| -83% | -$288K |
|
3670
Erasca
ERAS
$445M
| $60.3K | ﹤0.01% |
29,254
-2,544
| -8% | -$5.24K |
|
3671
Nerdy
NRDY
$165M
| $59.9K | ﹤0.01% |
20,587
-151
| -0.7% | -$439 |
|
3672
iShares Russell 2000 ETF
IWM
$67B
| $56.8K | ﹤0.01% |
270
-32,828
| -99% | -$6.9M |
|
3673
Zura Bio
ZURA
$133M
| $55.1K | ﹤0.01% |
21,456
-98,984
| -82% | -$254K |
|
3674
Denison Mines
DNN
$2.08B
| $54.6K | ﹤0.01% |
27,998
-115
| -0.4% | -$224 |
|
3675
Vuzix
VUZI
$164M
| $54.1K | ﹤0.01% |
44,690
+8,560
| +24% | +$10.4K |
|